Picture of Lee's Pharmaceutical Holdings logo

950 Lee's Pharmaceutical Holdings Cashflow Statement

0.000.00%
hk flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Annual cashflow statement for Lee's Pharmaceutical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.

2019
December 31st
2020
December 31st
2021
December 31st
2022
December 31st
2023
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:ARSARSARSARSARS
Standards:
HKAS
HKAS
HKAS
HKAS
HKAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line1231341,96967.930.8
Depreciation
Amortisation
Non-Cash Items135107-1,90271.628.1
Unusual Items
Equity in Net Earnings/Losses
Other Non-Cash Items
Changes in Working Capital47.7-149-3.45-8.36-98.3
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Other Operating Cash Flow
Cash from Operating Activities400219211284110
Capital Expenditures-361-358-371-214-160
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items99.2-1660.443-42.214.5
Acquisition of Business
Sale of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Purchase of Investments
Sale of Intangible Assets
Other Investing Cash Flow
Cash from Investing Activities-261-524-370-256-145
Financing Cash Flow Items40031.20
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities324-9.861-12913.4
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash471-318-97.7-88.2-21.8